Delivery Order 75N98019D00061-75N91023F00001
Award Date
8/1/23
Potential Completion Date
7/31/25
Potential Value
$791K
Federal Agency
National Cancer Institute
Awardee
Mriglobal
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Kansas City, MO 64110, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,415,116.56 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to Mriglobal, doing business as Midwest Research Institute, to provide shelf life evaluation of investigational dosage forms. The contract does not have a small business set-aside designation. Mriglobal is an independent, not-for-profit research organization that conducts over $110 million in research annually for federal and commercial...
This is a $25,543,276.37 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to the not-for-profit research organization Mriglobal (doing business as Midwest Research Institute). The contract is for the analysis of anti-cancer chemicals and pharmaceutical formulations. Mriglobal is a highly experienced federal contractor, holding several significant...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The contract has a ceiling value of $26,932,208.00 and an ultimate completion date of June 30, 2028. The contract is for a "Centralized Chemopreventive Agent Repository and Chemistry Support" and is not set aside for any specific business type. Mriglobal is a...
This is a Cost Plus Award Fee delivery order under a $1,283,149.00 contract awarded by the National Institute of Neurological Disorders and Stroke, a civilian agency, to Mriglobal (also known as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract is part of the Drug Manufacturing and Formulation Program (DMFP) master IDIQ, and the task is for the PADERI HEAL PROJECT-IHP-102. There is no set-aside designation for this award. Mriglobal is the prime...
This is a delivery order federal contract awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Mriglobal, doing business as Midwest Research Institute, a 501(c)(3) not-for-profit research organization. The $1,524,929.00 contract is for the manufacture of plasmid DNA drug substance and drug product. The period of performance runs through September 24, 2027. Mriglobal has been awarded multiple significant federal contracts and grants...
This is a $99,500.00 delivery order contract awarded to Mriglobal, also doing business as Midwest Research Institute, by the Department of Health and Human Services' National Institutes of Health National Institute on Aging. The contract is for drug toxicity testing services, with a period of performance through July 31, 2024. The contract is not set aside for any small business program. Mriglobal is a 501(c)(3) non-profit research organization that specializes in scientific research, testing,...
This is a Cost Plus Fixed Fee delivery order awarded to Mriglobal (also doing business as Midwest Research Institute), a 501(c)(3) not-for-profit research organization, by the National Institute of Neurological Disorders and Stroke (NINDS), a component of the Department of Health and Human Services (HHS). The $522,487.86 task order is for technical support services under the larger Drug Manufacturing and Formulation Program (DMFP). The work will be performed in Kansas City, Missouri. Two...
This is a delivery order awarded to Mriglobal, doing business as Midwest Research Institute, under a $3,500.00 Firm Fixed Price Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The contract was awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, for the Diagnostics Pre-Clinical Services Program. The contract has a period of performance through June 19, 2030. Mriglobal is a 501(c)(3) not-for-profit research organization that provides scientific...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $1,596,279.92 cost-plus-fixed-fee delivery order contract to Midwest Research Institute (doing business as Mriglobal), a not-for-profit research organization, under the Drug Manufacturing and Formulation Program (DMFP) indefinite delivery/indefinite quantity (IDIQ) contract. The contract does not have a set-aside designation. Key subcontractors include the University...
This is a delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency of the U.S. Department of Health and Human Services, to Mriglobal (doing business as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract is part of NIDA's Drug Manufacturing and Formulation Program (DMFP) and is for small-scale testing of convergent route processes. The contract has a ceiling value of $942,363.89 and does not have a set-aside...